New heart valve device aims to fix leaky valve without open surgery
NCT ID NCT07454980
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests a new device called LuX-Valve Plus for people with a severely leaky heart valve (tricuspid regurgitation). About 680 adults will get either the new device or a standard one to see which is safer and works better. Participants will have one procedure and be followed for check-ups and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION (TR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New artificial heart valve could help patients too sick for surgery
- Heart failure drug vericiguat faces new test in tricuspid regurgitation patients
- Heart rhythm disorder may reshape valve before leaks start
- Can early rhythm control save hearts in AF patients with leaky valves?
- New clip device tested for leaky heart valve fix
- Heart valve repair may unlock higher doses of key heart failure drugs